{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Castle Biosciences, Inc."},"Symbol":{"label":"Symbol","value":"CSTL"},"Address":{"label":"Address","value":"505 S. FRIENDSWOOD DRIVE,SUITE 401, FRIENDSWOOD, Texas, 77546, United States"},"Phone":{"label":"Phone","value":"+1 866 788-9007"},"Industry":{"label":"Industry","value":"Medical Specialities"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others."},"CompanyUrl":{"label":"Company Url","value":"https://www.castlebiosciences.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Chris Otte","title":"Vice President-Information Technology"},{"name":"Derek J. Maetzold","title":"President, Chief Executive Officer & Director"},{"name":"Johnson R.N. Clare","title":"Vice President-Clinical Research"},{"name":"Kristen M. Oelschlager","title":"Chief Operating Officer"},{"name":"Matthew Goldberg","title":"Vice President-Medical"},{"name":"Robert W. Cook","title":"Senior Vice President-Research & Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}